A Critique and Impact Analysis of Decision Modeling Assumptions
Author
Abstract
Suggested Citation
DOI: 10.1177/0272989X07300606
Download full text from publisher
References listed on IDEAS
- Michael Drummond, 1992. "Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?," Health Economics, John Wiley & Sons, Ltd., vol. 1(2), pages 85-92, July.
- Salkeld, Glenn & Phongsavan, Philayrath & Oldenburg, Brian & Johannesson, Magnus & Convery, Paula & Graham-Clarke, Peita & Walker, Sheila & Shaw, John, 1997. "The cost-effectiveness of a cardiovascular risk reduction program in general practice," Health Policy, Elsevier, vol. 41(2), pages 105-119, August.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Karen M. Kuntz & Elisabeth Fenwick & Andrew Briggs, 2010. "Appropriate Cohorts for Cost-Effectiveness Analysis: To Mix or Not to Mix?," Medical Decision Making, , vol. 30(4), pages 424-425, July.
- Christopher McCabe, 2007. "Guidance on Good Practice in Cost-Effectiveness Modeling: Is More Needed?," Medical Decision Making, , vol. 27(4), pages 350-351, July.
- Lee Goldman & Jean-Michel Gaspoz, 2008. "Cost-Effectiveness of Clopidogrel: Seeing through the Smoke," Medical Decision Making, , vol. 28(6), pages 803-809, November.
- Jonathan Karnon & Alan Brennan & Ron Akehurst, 2010. "Decision Modeling to Inform Decision Making: Seeing the Wood for the Trees," Medical Decision Making, , vol. 30(3), pages 20-22, May.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Robertson-Preidler, Joelle & Anstey, Matthew & Biller-Andorno, Nikola & Norrish, Alexandra, 2017. "Approaches to appropriate care delivery from a policy perspective: A case study of Australia, England and Switzerland," Health Policy, Elsevier, vol. 121(7), pages 770-777.
- Sanjib Saha & Ulf-G Gerdtham & Pia Johansson, 2010. "Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases," IJERPH, MDPI, vol. 7(8), pages 1-46, August.
- Christopher McCabe, 2007. "Guidance on Good Practice in Cost-Effectiveness Modeling: Is More Needed?," Medical Decision Making, , vol. 27(4), pages 350-351, July.
- James K. Hammitt, 2002. "QALYs Versus WTP," Risk Analysis, John Wiley & Sons, vol. 22(5), pages 985-1001, October.
- Clive Pritchard;Martin Sculpher, 2000. "Productivity Costs: Principles and Practice in Economic Evaluation," Monograph 000464, Office of Health Economics.
- Sanjib Saha & Katarina Steen Carlsson & Ulf-G Gerdtham & Margareta K Eriksson & Lars Hagberg & Mats Eliasson & Pia Johansson, 2013. "Are Lifestyle Interventions in Primary Care Cost-Effective? – An Analysis Based on a Markov Model, Differences-In-Differences Approach and the Swedish Björknäs Study," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-1, November.
- Ulla K. Griffiths & Benedict Anigbogu & Kiran Nanchahal, 2012. "Economic evaluations of adult weight management interventions," Applied Health Economics and Health Policy, Springer, vol. 10(3), pages 145-162, May.
- John Hutton, 1994. "Economic Evaluation of healthcare: A half‐way technology," Health Economics, John Wiley & Sons, Ltd., vol. 3(1), pages 1-4, January.
- Ulla Griffiths & Benedict Anigbogu & Kiran Nanchahal, 2012. "Economic evaluations of adult weight management interventions," Applied Health Economics and Health Policy, Springer, vol. 10(3), pages 145-162, May.
- Richard J. Willke & Henry A. Glick & Daniel Polsky & Kevin Schulman, 1998. "Estimating country‐specific cost‐effectiveness from multinational clinical trials," Health Economics, John Wiley & Sons, Ltd., vol. 7(6), pages 481-493, September.
- Trevor A. Sheldon, 1996. "Problems of using modelling in the economic evaluation of health care," Health Economics, John Wiley & Sons, Ltd., vol. 5(1), pages 1-11, January.
- Office of Health Economics, 1997. "The Pros and Cons of Modelling in Economic Evaluation," Briefing 000428, Office of Health Economics.
More about this item
Keywords
Key words: guidelines; models; decision support; cost-effectiveness; antiplatelet drugs. (Med Decis Making 2007; 27:491—499);All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:27:y:2007:i:4:p:491-499. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.